Efficacy News and Research

RSS

Cloth masks should be machine washed daily during COVID-19, study says

A team of researchers reports that cloth masks effectively protect against infection if they are washed every day. The researchers recommend daily washing of cloth masks at high temperatures to reduce the likelihood of contamination and transmission of viruses such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease (COVID-19).

11 Oct 2020

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

The emergence of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutation D614G has raised many questions, including whether it will cause the virus to become resistant to the vaccines produced against earlier versions of the virus. A new study published in the journal npj Vaccines in October 2020 shows that this may be an unfounded fear.

11 Oct 2020

CHLA investigator receives $3.4 million research grant to study rotavirus vaccine

Rotavirus (RV) is an extremely contagious viral infection and the most common cause of diarrhea in infants and children worldwide.

9 Oct 2020

New initiative identifies key parameters underlying effective anti-tumor immunity

Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.

9 Oct 2020

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.

9 Oct 2020

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

In June, two studies in Science reported an antibody cocktail against SARS-CoV-2 developed from studies in humanized mice and recovering patients. The two antibody cocktail was designed to bind the virus to reduce the risk of a drug-resistant form emerging.

9 Oct 2020

Mologic launches its first crop pathogen diagnostic test

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced the launch of its first crop pathogen diagnostic test, BotrytisAlert.

9 Oct 2020

Study offers new insights about myopia management

CooperVision is reporting the latest findings from its landmark MiSight® 1 day clinical study, providing new insights about myopia management and the proven efficacy of the specially designed contact lens.

9 Oct 2020

Neurobiologists decode central mechanism of degenerative processes in brains of mouse models

Heidelberg neurobiologists decode central mechanism of degenerative processes in the brains of mouse models and develop new principle for therapeutic agents

9 Oct 2020

NIH clinical trial to test a combination treatment regimen for COVID-19

A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.

8 Oct 2020

Detection of SARS-CoV-2 viral persistence in built environments

In a recent paper in an open-access journal, mSystems, published by The American Society for Microbiology, Ceth W. Parker et al. show challenges in recovering the virus, change in infectivity, and the case of viral persistence in built environments.

8 Oct 2020

FDA reaffirms commitment to protect laboratory safety and security

The U.S. Food and Drug Administration's mission to protect and promote public health by ensuring the safety of the nation's food supply, as well as the safety and efficacy of medical products, has always relied on a rigorous analysis of the scientific data available and a strong commitment to safety.

8 Oct 2020

Face masks far more protective against COVID-19 than face shields, CDC experts

Researchers from the Centers for Disease Control and Prevention (CDC) have conducted a study showing that face masks and neck gaiters appear to be much more effective than face shields at reducing the expulsion of respiratory aerosols that could potentially transmit severe acute respiratory syndrome 2 (SARS-CoV-2).

8 Oct 2020

Efficacy News and Research

Cloth masks should be machine washed daily during COVID-19, study says

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

CHLA investigator receives $3.4 million research grant to study rotavirus vaccine

New initiative identifies key parameters underlying effective anti-tumor immunity

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

Mologic launches its first crop pathogen diagnostic test

Study offers new insights about myopia management

Neurobiologists decode central mechanism of degenerative processes in brains of mouse models

NIH clinical trial to test a combination treatment regimen for COVID-19

Detection of SARS-CoV-2 viral persistence in built environments

FDA reaffirms commitment to protect laboratory safety and security

Face masks far more protective against COVID-19 than face shields, CDC experts

Leopoldina appeals to governments to take protective measures on COVID-19 pandemic

Warwick researcher to explore the use of robots and artificial intelligence in hospital settings

Study: New viral mutations would not impact the efficacy of Covid-19 vaccine candidates

New computer program detects neurodegeneration biomarkers through magnetic resonance imaging

Researchers launch innovative app for tracking COVID-19 around the world

Study: Thymoquinone selectively kills prostate cancer cells at advanced stages

Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News